Kadaba (Sri) S Sriprakash
Professor Sri Sriprakash graduated from the Indian Institute of Science, Bangalore, India in 1970. His PhD work was on mode of action of isoniazid and mechanism of resistance to this drug in Mycobacterium tuberculosis. Between 1970 and 1973 he was a Postdoctoral Fellow at Yale University School of Medicine, USA where he demonstrated the first in vitro recombination in phage lambda.
Sri then moved to Monash University, Melbourne, Australia in 1973. The work there showed the first correlation between genetic and physical maps of mitochondria in the yeast Saccharomyces cerevisiae. He then moved to the Australian National University, Canberra to extend his work on yeast mitochondrial molecular genetics.
Professor Sriprakash was appointed in 1985 as head of Molecular Genetics Laboratory at Menzies School of Health Research, Darwin where he commenced work on Chlamydia and Streptococcus. In 2001 he moved to Queensland Institute of Medical Research as the head of Bacterial Pathogenesis Group. Over the last decade he established extensive collaboration with scientists in India. His recent collaborative work shows that past infections with some strains of streptococci is an independent risk factor for chronic renal disease.
He retired in 2015. He is now affiliated with the Scabies Group at QIMR Berghofer Medical Research Institute.
Abstracts this author is presenting: